Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

By sjmartinez • January 5, 2024

Dejaco C, Kerschbaumer A, Aletaha D, Bond M, Hysa E, Camellino D, Ehlers L, Abril A, Appenzeller S, Cid MC, Dasgupta B, Duftner C, Grayson PC, Hellmich B, Hočevar A, Kermani TA, Matteson EL, Mollan SP, Neill L, Ponte C, Salvarani C, Sattui SE, Schmidt WA, Seo P, Smolen JS, Thiel J, Toro-Gutiérrez CE, Whitlock M, Buttgereit F. Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica. Ann Rheum Dis. 2024 Jan 2;83(1):48-57. doi: 10.1136/ard-2022-223429. PMID: 36828585.

Tags: biological therapy, giant cell arteritis, Health care, Outcome and Process Assessment, polymyalgia rheumatica, Publications, Rheumatology

Mitochondrial oxidants promote platelet activation and thrombotic susceptibility in prediabetes

Ahmed A, Yadav P, Jensen M, Geasland K, Swamy J, Spitz DR, Abel ED, Jalal D, Dayal S. Mitochondrial oxidants promote platelet activation and thrombotic[...]

DaRE to Approach Differently: Teaching the Digital Anorectal Examination Through a Trauma-Informed Framework

Kwan K, Labora A, Chen F, Solorzano W, Gonzalez D, Orji W, Russell T. DaRE to Approach Differently: Teaching the Digital Anorectal Examination Through a[...]

Facial Swelling in a Young Adult With Type 1 Diabetes: Morbihan Disease as a Scleroderma Mimic

Shammas R, Gudino-Rosales S, Kneiber D, Sarantopoulos GP, Aung T. Facial Swelling in a Young Adult With Type 1 Diabetes: Morbihan Disease as a Scleroderma[...]